Project Twenty21, Europe’s largest ever medical cannabis patient study, has released its first preliminary results – the first real-world data to be published on medical cannabis patients in the United Kingdom.
As zebrafish are accepted models for humans in scientific research (much like mice), the authors of the study say that these observed effects of prenatal cannabis exposure could be mirrored in humans.
The researchers found that while restrictive intervention does appear to decrease the share of adolescents initiating cannabis use, there was no evidence of policy changes impacting the share of frequent cannabis users.
The use of MDMA-assisted therapy for post-traumatic stress disorder (PTSD) has now proven itself in its first phase 3 clinical trial.
Research shows understanding teen use helps develop effective prevention programs.
Study finds adults age 50 and older with functional impairments use medical cannabis more and are more likely to suffer from prescription opioid and tranquilizer/sedative use and misuse.
This comes after the FDA also recently allowed institutes to conduct clinical trials on MDMA and its therapeutic potential in treating PTSD.
Crucially, the scientists say, the benefits of the drug came without the cost of hallucinations, a side effect which may aggravate stress.